Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder

Details for Australian Patent Application No. 2001280699 (hide)

Event Publications

15 March 2007 Assignment before Grant

Yissum Research Development Company of the Hebrew University of Jerusalem; Teva Pharmaceutical Industries, Ltd. The application has been assigned to Yissum Research Development Company of the Hebrew University of Jerusalem

19 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.